Scholarlink

Background <p>Cancer arises through coordinated disruption of genome integrity, epigenetic regulation, and cellular metabolism, producing heterogeneous phenotypes that enable uncontrolled growth, immune evasion, invasion, and metastasis. Because these processes operate as an interconnected system rather than isolated pathways, an integrated synthesis is needed to clarify how tumors evolve and why resistance emerges across diverse clinical contexts.</p> Main body <p>This review synthesizes key molecular events that initiate and sustain carcinogenesis, emphasizing mechanistic coupling among genomic instability, epigenetic remodeling, and metabolic adaptation. Defects in cell-cycle checkpoints, telomere maintenance, and DNA repair accelerate mutational accumulation and clonal diversification. Epigenetic control of gene expression is examined through DNA methylation, histone modifications, chromatin remodeling, and regulatory non-coding RNAs, including how epigenetic drift can stabilize malignant transcriptional programs and modulate DNA damage responses. Metabolic reprogramming is discussed beyond aerobic glycolysis, focusing on context-dependent shifts between glycolysis and oxidative phosphorylation shaped by hypoxia-inducible factor signaling, mitochondrial dysfunction, and mitochondrial DNA alterations. The resulting changes in redox balance and metabolite availability influence chromatin-modifying enzymes and genome maintenance pathways, creating feedback loops that support survival under microenvironmental stress. These molecular programs are linked to tumor progression through angiogenic signaling and epithelial–mesenchymal transition, in which loss of E-cadherin and transcriptional reprogramming promote dissemination. Translational implications are outlined through representative therapeutic classes, including next-generation targeted agents, anti-angiogenic strategies, immunotherapies, epigenetic modulators, and metabolism-directed interventions, with emphasis on rationale for combination approaches that constrain adaptive escape.</p> Conclusion <p>Establishing that carcinogenesis operates through coupled genetic, epigenetic, and metabolic mechanisms provides a coherent framework for interpreting tumor heterogeneity and therapy resistance. Organizing evidence around shared interaction nodes supports more mechanism-driven biomarker selection and more durable, context-aware therapeutic strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Charting the molecular landscape of cancer: from genomic chaos to epigenetic control and energetic adaptation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月17日

查看全文
  • Hussam S. Aziz,
  • Noor Alhuda R. Mohammed,
  • Yousef Husam Abdulhameed,
  • Abdullah Ayad

摘要

Background

Cancer arises through coordinated disruption of genome integrity, epigenetic regulation, and cellular metabolism, producing heterogeneous phenotypes that enable uncontrolled growth, immune evasion, invasion, and metastasis. Because these processes operate as an interconnected system rather than isolated pathways, an integrated synthesis is needed to clarify how tumors evolve and why resistance emerges across diverse clinical contexts.

Main body

This review synthesizes key molecular events that initiate and sustain carcinogenesis, emphasizing mechanistic coupling among genomic instability, epigenetic remodeling, and metabolic adaptation. Defects in cell-cycle checkpoints, telomere maintenance, and DNA repair accelerate mutational accumulation and clonal diversification. Epigenetic control of gene expression is examined through DNA methylation, histone modifications, chromatin remodeling, and regulatory non-coding RNAs, including how epigenetic drift can stabilize malignant transcriptional programs and modulate DNA damage responses. Metabolic reprogramming is discussed beyond aerobic glycolysis, focusing on context-dependent shifts between glycolysis and oxidative phosphorylation shaped by hypoxia-inducible factor signaling, mitochondrial dysfunction, and mitochondrial DNA alterations. The resulting changes in redox balance and metabolite availability influence chromatin-modifying enzymes and genome maintenance pathways, creating feedback loops that support survival under microenvironmental stress. These molecular programs are linked to tumor progression through angiogenic signaling and epithelial–mesenchymal transition, in which loss of E-cadherin and transcriptional reprogramming promote dissemination. Translational implications are outlined through representative therapeutic classes, including next-generation targeted agents, anti-angiogenic strategies, immunotherapies, epigenetic modulators, and metabolism-directed interventions, with emphasis on rationale for combination approaches that constrain adaptive escape.

Conclusion

Establishing that carcinogenesis operates through coupled genetic, epigenetic, and metabolic mechanisms provides a coherent framework for interpreting tumor heterogeneity and therapy resistance. Organizing evidence around shared interaction nodes supports more mechanism-driven biomarker selection and more durable, context-aware therapeutic strategies.